Novel binders derived from an albumin-binding domain scaffold targeting human prostate secretory protein 94 (PSP94)
Language English Country Germany Media print
Document type Letter, Research Support, Non-U.S. Gov't
PubMed
26264490
PubMed Central
PMC4598320
DOI
10.1007/s13238-015-0194-9
PII: 10.1007/s13238-015-0194-9
Knihovny.cz E-resources
- MeSH
- Albumins metabolism MeSH
- Humans MeSH
- Molecular Sequence Data MeSH
- Prostatic Secretory Proteins chemistry metabolism MeSH
- Amino Acid Sequence MeSH
- Protein Structure, Tertiary MeSH
- Protein Binding MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Albumins MeSH
- beta-microseminoprotein MeSH Browser
- Prostatic Secretory Proteins MeSH
Institute of Microbiology Czech Academy of Sciences v v i Vídeňská 1083 142 20 Prague Czech Republic
See more in PubMed
Ahmad JN, Li J, Biedermannova L, Kuchar M, Sipova H, Semeradtova A, Cerny J, Petrokova H, Mikulecky P, Polinek J, et al. Novel high-affinity binders of human interferon gamma derived from albumin-binding domain of protein G. Proteins. 2012;80(3):774–789. doi: 10.1002/prot.23234. PubMed DOI
Anahi Franchi N, Avendano C, Molina RI, Tissera AD, Maldonado CA, Oehninger S, Coronel CE. β-Microseminoprotein in human spermatozoa and its potential role in male fertility. Reproduction. 2008;136(2):157–166. doi: 10.1530/REP-08-0032. PubMed DOI
Anklesaria JH, Jagtap DD, Pathak BR, Kadam KM, Joseph S, Mahale SD. Prostate Secretory Protein of 94 amino acids (PSP94) binds to prostatic acid phosphatase (PAP) in human seminal plasma. PLoS One. 2013;8(3):e58631. doi: 10.1371/journal.pone.0058631. PubMed DOI PMC
Annabi B, Currie JC, Bouzeghrane M, Dulude H, Daigneault L, Garde S, Rabbani SA, Panchal C, Wu JJ, Beliveau R. Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding. Biochem Biophys Res Commun. 2006;346(1):358–366. doi: 10.1016/j.bbrc.2006.05.139. PubMed DOI
FitzGerald LM, Zhang X, Kolb S, Kwon EM, Liew YC, Hurtado-Coll A, Knudsen BS, Ostrander EA, Stanford JL. Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression. Hum Mutat. 2013;34(1):149–156. doi: 10.1002/humu.22176. PubMed DOI PMC
Gilbreth RN, Koide S. Structural insights for engineering binding proteins based on non-antibody scaffolds. Curr Opin Struct Biol. 2012;22(4):413–420. doi: 10.1016/j.sbi.2012.06.001. PubMed DOI PMC
Kuchar M, Vankova L, Petrokova H, Cerny J, Osicka R, Pelak O, Sipova H, Schneider B, Homola J, Sebo P, et al. Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cells. Proteins. 2014;82(6):975–989. doi: 10.1002/prot.24472. PubMed DOI PMC
Lazzeri M, Briganti A, Scattoni V, Lughezzani G, Larcher A, Gadda GM, Lista G, Cestari A, Buffi N, Bini V, et al. Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy. J Urol. 2012;188(4):1137–1143. doi: 10.1016/j.juro.2012.06.017. PubMed DOI
Lou H, Yeager M, Li H, Bosquet JG, Hayes RB, Orr N, Yu K, Hutchinson A, Jacobs KB, Kraft P, et al. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci USA. 2009;106(19):7933–7938. doi: 10.1073/pnas.0902104106. PubMed DOI PMC
Manaskova-Postlerova P, Davidova N, Sulc M, Philimonenko A, Hozak P, Jonakova V. Reproductive tissue expression and sperm localization of porcine beta-microseminoprotein. Cell Tissue Res. 2011;344(2):341–353. doi: 10.1007/s00441-011-1149-y. PubMed DOI
Mhatre DR, Mahale SD, Khatkhatay MI, Desai SS, Jagtap DD, Dhabalia JV, Tongaonkar HB, Desai MP, Dandekar SP, Varadkar AM. Development of an ELISA for sPSP94 and utility of the sPSP94/sPSA ratio as a diagnostic indicator to differentiate between benign prostatic hyperplasia and prostate cancer. Clin Chim Acta. 2014;436:256–262. doi: 10.1016/j.cca.2014.06.006. PubMed DOI
Nam RK, Reeves JR, Toi A, Dulude H, Trachtenberg J, Emami M, Daigneault L, Panchal C, Sugar L, Jewett MA, et al. A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis. J Urol. 2006;175(4):1291–1297. doi: 10.1016/S0022-5347(05)00695-6. PubMed DOI
Reeves JR, Dulude H, Panchal C, Daigneault L, Ramnani DM. Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy. Clin Cancer Res. 2006;12(20 Pt 1):6018–6022. doi: 10.1158/1078-0432.CCR-06-0625. PubMed DOI
Velonas VM, Woo HH, Remedios CG, Assinder SJ. Current status of biomarkers for prostate cancer. Int J Mol Sci. 2013;14(6):11034–11060. doi: 10.3390/ijms140611034. PubMed DOI PMC
Yang JP, Finkelman MA, Clarke MW. Detection of PSP94 and its specific binding sites in the prostate adenocarcinoma cell line LNCaP. J Urol. 1998;160(6 Pt 1):2240–2244. doi: 10.1097/00005392-199812010-00093. PubMed DOI
Targeting Human Thrombus by Liposomes Modified with Anti-Fibrin Protein Binders
